Yes, the Serum Institute of India, one of the world's largest vaccine manufacturers, is planning to invest £50 million in Oxford Biomedica, a UK-based company specializing in cell and gene therapy. To understand the reason behind this investment, leverage pharma company-based actionable org charts developed by sales intelligence experts.

The actionable account maps provide a clear picture of the organizational structure, key stakeholders, and internal dynamics of Serum Institute of India. By leveraging this information, B2B marketers can improve targeting, build stronger relationships, and stay informed about strategic changes. Ultimately, it will lead to more effective marketing campaigns and better business outcomes.

You can view Org Charts HERE.

oxford-biomedica-(uk)-limited - Org Chart
Science. Service. Solutions. We are a quality and innovation-led CDMO with over 25 years of experience, committed to helping our clients deliver cell and gene therapies that transform patients? lives. We offer end-to-end capabilities, from plasmid design and optimisation, to clinical and commercial CGMP manufacturing, accompanied by robust control systems, analytical methods and deep regulatory knowledge. Our expertise across lentivirus, AAV, and adenoviral vectors is relied upon by some of the world?s most successful biotechnology and pharmace... Read more
View question
About · Careers · Privacy · Terms · Contact · Languages · Your Ad Choices · Press ·
© Quora, Inc. 2025